Absolute Configuration Determination of Chiral API Molecules by MicroED Analysis of Cocrystal Powders Formed Based on Cocrystal Propensity Prediction Calculations**

Author:

Shah Harsh S.1ORCID,Yuan Jiuchuang2ORCID,Xie Tian1,Yang Zhuocen2,Chang Chao2,Greenwell Chandler3ORCID,Zeng Qun2,Sun GuangXu2,Read Brandon N.4,Wilson Timothy S.4,Valle Henry U.4ORCID,Kuang Shanming1,Wang Jian1,Sekharan Sivakumar3ORCID,Bruhn Jessica F.4ORCID

Affiliation:

1. J-STAR Research Inc. 6 Cedar Brook Dr Cranbury NJ 08512 USA

2. XtalPi Inc. Shenzhen Jingtai Technology Co. Ltd International Biomedical Innovation Park II 3F No. 2 Hongliu Road, Futian District Shenzhen 518100 China

3. XtalPi Inc. 245 Main St, 11th Floor Cambridge MA 02142 USA

4. NanoImaging Services Inc. 4940 Carroll Canyon Road, Suite 115 San Diego CA 92121 USA

Abstract

AbstractEstablishing the absolute configuration of chiral active pharmaceutical ingredients (APIs) is of great importance. Single crystal X‐ray diffraction (scXRD) has traditionally been the method of choice for such analysis, but scXRD requires the growth of large crystals, which can be challenging. Here, we present a method for determining absolute configuration that does not rely on the growth of large crystals. By examining microcrystals formed with chiral probes (small chiral compounds such as amino acids), absolute configuration can be unambiguously determined by microcrystal electron diffraction (MicroED). Our streamlined method employs three steps: (1) virtual screening to identify promising chiral probes, (2) experimental cocrystal screening and (3) structure determination by MicroED and absolute configuration assignment. We successfully applied this method to analyze two chiral API molecules currently on the market for which scXRD was not used to determine absolute configuration.

Publisher

Wiley

Subject

General Chemistry,Catalysis,Organic Chemistry

Reference44 articles.

1. U. S. F. & D. Administration “Novel Drug Approvals for 2021 ” can be found underhttps://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2021 n.d.

2. The determination of the absolute configurations of chiral molecules using vibrational circular dichroism (VCD) spectroscopy

3. Determination of Absolute Configuration of Chiral Molecules Using Vibrational Optical Activity: A Review

4. The Assignment of Absolute Configuration by NMR

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3